Clinical utility of endoscopic ultrasound-guided fine-needle aspiration in mixed adenoneuroendocrine carcinoma with signet-ring cells of the pancreas: a case report and review of the literature
Tóm tắt
Từ khóa
Tài liệu tham khảo
Bosman FT, Carneiro F, Hruban RH, et al. WHO classification of tumours of the digestive system. Lyon: IARC Press; 2010.
Fukuba N, Yuki T, Ishihara S, et al. Gastric mixed adenoneuroendocrine carcinoma with a good prognosis. Intern Med. 2014;53:2585–8.
Mandys V, Jirasek T. Spectrum of gastroenteropancreatic NENs in routine histological examinations of bioptic and surgical specimen: a study of 161 cases collected from 17 Departments of Pathology in the Czech Republic. Gastroenterol Res Pract. 2014. doi: 10.1155/2014/373828 .
Lee L, Bajor-Dattilo EB, Das K. Metastatic mixed acinar-neuroendocrine carcinoma of the pancreas to the liver: a cytopathology case report with review of the literature. Diagn Cytopathol. 2013;41:164–70.
Onishi I, Kitagawa H, Harada K, et al. Intraductal papillary neoplasm of the bile duct accompanying biliary mixed adenoneuroendocrine carcinoma. World J Gastroenterol. 2013;19:3161–4.
Li Y, Yau A, Schaeffer D, et al. Colorectal glandular-neuroendocrine mixed tumor: pathologic spectrum and clinical implications. Am J Surg Pathol. 2011;35:413–25.
Vanacker L, Smeets D, Hoorens A, et al. Mixed adenoneuroendocrine carcinoma of the colon: molecular pathogenesis and treatment. Anticancer Res. 2014;34:5517–21.
Kyriazi MA, Arkadopoulos N, Stafyla VK, et al. Mixed acinar-endocrine carcinoma of the pancreas: a case report and review of the literature. Cases J. 2009;2:6481.
Sullivan PS, Clebanoff JL, Hirschowitz SL. Hints to the diagnosis of mixed acinar-endocrine carcinoma on pancreatic fine-needle aspiration: avoiding a potential diagnostic pitfall. Acta Cytol. 2013;57:296–302.
Bhosale PR, Menias CO, Balachandran A, et al. Vascular pancreatic lesions: spectrum of imaging findings of malignant masses and mimics with pathologic correlation. Abdom Imaging. 2013;38:802–17.
Petrone MC, Arcidiacono PG. Basic technique in endoscopic ultrasound-guided fine needle aspiration for solid lesions: how many passes? Endosc Ultrasound. 2014;3:22–7.
Piani C, Franchi GM, Cappelletti C, et al. Cytological Ki-67 in pancreatic endocrine tumours: an opportunity for pre-operative grading. Endocr Relat Cancer. 2008;15:175–81.
Chatzipantelis P, Konstantinou P, Kaklamanos M, et al. The role of cytomorphology and proliferative activity in predicting biologic behavior of pancreatic neuroendocrine tumors: a study by endoscopic ultrasound-guided fine-needle aspiration cytology. Cancer. 2009;117:211–6.
Yang Z, Tang LH, Klimstra DS. Effect of tumor heterogeneity on the assessment of Ki67 labeling index in well-differentiated neuroendocrine tumors metastatic to the liver: implications for prognostic stratification. Am J Surg Pathol. 2011;35:853–60.
Terada T. Primary signet-ring cell carcinoma of the pancreas diagnosed by endoscopic retrograde pancreatic duct biopsy: a case report with an immunohistochemical study. Endoscopy. 2012;44:E141–2.
Tracey KJ, O’Brien MJ, Williams LF, et al. Signet ring cell carcinoma of the pancreas, a rare variant with very high CEA values; immunohistologic comparison with adenocarcinoma. Dig Dis Sci. 1984;29:573–6.
Chow LT, Chow WH. Signet-ring mucinous adenocarcinoma of the pancreas. Chin Med Sci J. 1994;3:176–8.
McAuthur CP, Fiorella R, Saran BM. Rare primary signet ring cell carcinoma of the pancreas. Mol Med. 1995;92:298–302.
Tang LH, Shia J, Soslow RA, et al. Pathologic classification and clinical behavior of the spectrum of goblet cell carcinoid tumors of the appendix. Am J Surg Pathol. 2008;32:1429–43.
Zhang L, DeMay RM. Cytological features of mixed adenoneuroendocrine carcinoma of the ampulla: two case reports with review of literature. Diagn Cytopathol. 2014;42:1075–84.
Bartley AN, Rashid A, Fournier KF, et al. Neuroendocrine and mucinous differentiation in signet ring cell carcinoma of the stomach: evidence for a common cell of origin in composite tumors. Hum Pathol. 2011;42:1420–9.
Harada K, Sato Y, Ikeda H, et al. Clinicopathologic study of mixed adenoneuroendocrine carcinomas of hepatobiliary organs. Virchows Arch. 2012;460:281–9.
Terashima T, Morizane C, Hiraoka N, et al. Comparison of chemotherapeutic treatment outcomes of advanced extrapulmonary neuroendocrine carcinomas and advanced small-cell lung carcinoma. Neuroendocrinology. 2012;96:324–32.
Fazio N, Spada F, Giovannini M. Chemotherapy in gastroenteropancreatic (GEP) neuroendocrine carcinomas (NEC): a critical view. Cancer Treat Rev. 2013;39:270–4.
Tomimaru Y, Eguchi H, Tatsumi M, et al. Clinical utility of 2-[18F] fluoro-2-deoxy-d-glucose positron emission tomography in predicting World Health Organization grade in pancreatic neuroendocrine tumors. Surgery. 2014. doi: 10.1016/j.surg.2014.09.011 .
Eriksson B, Bergström M, Sundin A, et al. The role of PET in localization of neuroendocrine and adreno-cortical tumors. Ann N Y Acad Sci. 2002;970:159–69.